Digital Twins Tentatively Finding Traction in the Pharmaceutical Industry

by Tancred Taylor | 3Q 2020 | IN-5904
While asset and process twins have seen significant interest and adoption in the manufacturing space, the pharmaceutical industry is one where uptake has been much slower. The technologies are, however, increasingly seeing development by digital twin technology suppliers; as accuracy and capabilities mature, digital twins will drive reams of new applications in the pharmaceutical space.

You must be a subscriber to view this ABI Insight.

To find out more about subscribing contact a representative about purchasing options.

Service